Norden Group LLC Boosts Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Norden Group LLC boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,139 shares of the company’s stock after buying an additional 235 shares during the period. Norden Group LLC’s holdings in U.S. Physical Therapy were worth $456,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of USPH. State Street Corp increased its stake in U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares in the last quarter. Copeland Capital Management LLC increased its stake in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after buying an additional 72,715 shares in the last quarter. Southernsun Asset Management LLC increased its stake in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after buying an additional 52,062 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $3,526,000. Finally, Rockefeller Capital Management L.P. grew its position in shares of U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares in the last quarter.

U.S. Physical Therapy Trading Down 2.1 %

Shares of U.S. Physical Therapy stock opened at $79.31 on Tuesday. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of 84.37, a PEG ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a 50 day moving average of $88.20 and a 200 day moving average of $87.65.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.27%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is 97.83%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.70% of the stock is owned by insiders.

Analyst Ratings Changes

USPH has been the subject of a number of analyst reports. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday. Barrington Research dropped their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday. Finally, Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $111.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.